v3.26.1
Debt and Finance Leases (Tables)
 3 Months Ended
Mar. 28, 2026
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Instruments
March 28, 2026December 31, 2025
ABL Credit Facility due November 2029: $88 million net availability and weighted average interest rate of 6.4% at March 28, 2026(a)
$19,750 $50,000 
2029 Term Loan due October 2029: interest rate of 11.2% at March 28, 2026
693,000 693,000 
5.50% CAD-based term loan due April 2028
18,680 18,923 
BioNova debt(b)
19,726 20,578 
Asset financing obligation18,648 — 
Other loans(c)
30,865 32,019 
Short-term factoring facility1,508 4,801 
Finance lease obligation335 456 
Total principal payments due802,512 819,777 
Less: unamortized premium, discount and issuance costs(39,098)(40,759)
Total debt$763,414 $779,018 
Debt due within one year$27,954 $20,909 
Long-term debt$735,460 $758,109 
(a)At March 28, 2026, the Company had $161 million of gross availability and net available borrowings of $88 million after taking into account the facility’s quarter end balance of $20 million, outstanding letters of credit of $29 million and required availability of $24 million to avoid triggering the facility’s fixed charge coverage ratio covenant.
(b)Consists of green loans associated with the France bioethanol plant, part of the net assets contributed by the Company to its subsidiary, BioNova.
(c)Consist of loans for energy projects in France.